Worth reading
55In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
9000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly report on the exercise status of stock acquisition rights with an exercise price adjustment clause
発行・処分する株式数
9,000 new shares (number of shares delivered in October 2026)
発行済株式総数
Exercise ratio subject to exercise restrictions: 0.01% (9,000 shares delivered across all series combined / 71,981,758 listed shares outstanding as of the payment date for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥94 (1 October 2026). Details of the adjustment provisions and the lower limit: Not disclosed
Number of Stock Acquisition Rights
Exercise ratio relative to the total number issued: 0.02%. 90 rights exercised during the month, 250,370 rights unexercised at the end of the previous month, and 250,280 rights unexercised at month-end
Procedures under the Corporate Code of Conduct
Describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters
Most recent equity financing
Series 22 Stock Acquisition Rights issued on 30 October 2025 (with provisions for adjustment of the exercise price). Amounts such as the issue price: Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly report on the exercise status of stock acquisition rights with an exercise price adjustment clause |
| Number of shares to be issued or disposed of | 9,000 new shares (number of shares delivered in October 2026) |
| Dilution Rate | Exercise ratio subject to exercise restrictions: 0.01% (9,000 shares delivered across all series combined / 71,981,758 listed shares outstanding as of the payment date for the issuance) |
| Total number of issued shares | 90,945,458 shares (as of the end of September 2026, including 32,329 treasury shares) → Not disclosed |
| Exercise price | ¥94 (1 October 2026). Details of the adjustment provisions and the lower limit: Not disclosed |
| Number of Stock Acquisition Rights | Exercise ratio relative to the total number issued: 0.02%. 90 rights exercised during the month, 250,370 rights unexercised at the end of the previous month, and 250,280 rights unexercised at month-end |
| Procedures under the Corporate Code of Conduct | Describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters |
| Most recent equity financing | Series 22 Stock Acquisition Rights issued on 30 October 2025 (with provisions for adjustment of the exercise price). Amounts such as the issue price: Not disclosed |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status in October 2026 of the Series 22 Stock Acquisition Rights issued on 30 October 2025.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.